Pancuronium
Pavulon (pancuronium) is a small molecule pharmaceutical. Pancuronium was first approved as Pavulon on 1982-01-01. The pharmaceutical is active against acetylcholine receptor subunit alpha.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Pancuronium bromide
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PAVULON | Organon | N-017015 DISCN | 1982-01-01 | 2 products, RLD |
Hide discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
pancuronium bromide | ANDA | 2019-01-31 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
35 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 2 | — | 3 | — | 5 |
Metabolic bone diseases | D001851 | HP_0000938 | — | 1 | — | 3 | 1 | 5 | |
Osteoporosis | D010024 | EFO_0003882 | M81.0 | 1 | 2 | — | 1 | 1 | 4 |
Osteogenesis imperfecta | D010013 | Q78.0 | — | — | 1 | 1 | 1 | 3 | |
Neoplasms | D009369 | C80 | 1 | — | — | 1 | — | 2 | |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | — | 2 | — | 2 | |
Prostatic neoplasms | D011471 | C61 | — | — | — | 1 | — | 1 | |
Bone diseases | D001847 | M89.9 | — | — | — | 1 | — | 1 | |
Chronic kidney disease-mineral and bone disorder | D012080 | EFO_1001152 | N25.0 | — | — | — | 1 | — | 1 |
Osteitis deformans | D010001 | EFO_0004261 | M88 | — | — | — | 1 | — | 1 |
Show 2 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Low back pain | D017116 | HP_0003419 | M54.5 | 2 | 2 | — | — | — | 3 |
Pain | D010146 | EFO_0003843 | R52 | 1 | 1 | — | — | 1 | 2 |
Drug therapy | D004358 | — | 1 | — | — | — | 1 | ||
Magnetic resonance imaging | D008279 | — | 1 | — | — | — | 1 | ||
Back pain | D001416 | HP_0003418 | M54 | — | 1 | — | — | — | 1 |
Intervertebral disc degeneration | D055959 | HP_0008419 | — | 1 | — | — | — | 1 |
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acquired hyperostosis syndrome | D020083 | EFO_1001164 | 1 | — | — | — | — | 1 | |
Arthroplasty | D001178 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Bone density | D015519 | EFO_0003923 | M85 | — | — | — | — | 1 | 1 |
Femur head necrosis | D005271 | — | — | — | — | 1 | 1 | ||
Cerebral palsy | D002547 | G80 | — | — | — | — | 1 | 1 | |
Spinal dysraphism | D016135 | EFO_1001210 | Q05 | — | — | — | — | 1 | 1 |
Heterotopic ossification | D009999 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PANCURONIUM |
INN | pancuronium bromide |
Description | Pancuronium bromide is a bromide salt consisting of two bromide ions and one pancuronium dication. It has a role as a muscle relaxant, a cholinergic antagonist and a nicotinic antagonist. It contains a pancuronium. |
Classification | Small molecule |
Drug class | quaternary ammonium derivatives: neuromuscular blocking agents; quaternary ammonium derivatives: neuromuscular blocking agents |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1[N+]1(C)CCCCC1 |
Identifiers
PDB | — |
CAS-ID | 15500-66-0 |
RxCUI | 7884 |
ChEMBL ID | CHEMBL185073 |
ChEBI ID | 7907 |
PubChem CID | 27350 |
DrugBank | DB01337 |
UNII ID | U9LY9Y75X2 (ChemIDplus, GSRS) |
Target
Agency Approved
CHRNA1
CHRNA1
Organism
Homo sapiens
Gene name
CHRNA1
Gene synonyms
ACHRA, CHNRA
NCBI Gene ID
Protein name
acetylcholine receptor subunit alpha
Protein synonyms
acetylcholine receptor, nicotinic, alpha 1 (muscle), cholinergic receptor, nicotinic alpha 1, cholinergic receptor, nicotinic, alpha 1 (muscle), cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle), muscle nicotinic acetylcholine receptor, nicotinic acetylcholine receptor alpha subunit, nicotinic cholinergic receptor alpha 1
Uniprot ID
Mouse ortholog
Chrna1 (11435)
acetylcholine receptor subunit alpha (P04756)
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 5,701 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
13,541 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more